Search
LuLym-T
go.drugbank.com/drugs/DB17405ExperimentalLuLym-T is an investigational autologous immune cell therapy consisting of activated T Lymphocytes. Developed by Lukas Biomedical, Inc., it is currently being investigated in hepatocellular carcinoma.
Levcromakalim
go.drugbank.com/drugs/DB21154InvestigationalLevcromakalim is under investigation in clinical trial NCT04853797 (Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM)). … Levcromakalim is a small molecule drug. The usage of the INN stem '-kalim' in the name indicates that Levcromakalim is a potassium channel activator, antihypertensive.
Chlormadinone
go.drugbank.com/drugs/DB13528InvestigationalCategories: Hormonal Contraceptives for Systemic UseBenzophenone
go.drugbank.com/drugs/DB01878ApprovedBenzophenone is the organic compound. Substituted benzophenones such as oxybenzone and dioxybenzone are used in sunscreen.
SCB-2019
go.drugbank.com/drugs/DB15805InvestigationalAs of June 2020, the company is pursuing a randomized, double blind, placebo controlled study (NCT04405908) to test the safety and immunogenicity of the vaccine. … SCB-2019 is a recombinant trimeric S protein subunit vaccine candidate being investigated against COVID-19.
Meptazinol
go.drugbank.com/drugs/DB13478ExperimentalCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromePhenazocine
go.drugbank.com/drugs/DB13606ExperimentalCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeBrolamfetamine
go.drugbank.com/drugs/DB01484ExperimentalIllicitCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome